InvestorsHub Logo

vinmantoo

10/03/22 1:03 PM

#2319 RE: DewDiligence #2318

ENTA starts phase-2b trial_of EDP-938 in high-risk adults:



Good to see EDP-938 moving forward. Now if we can only hear about the start of the phase 2 or phase 2/3 trial of EDP-235 in high risk people infected with Covid.

willyw

10/15/22 6:40 AM

#2322 RE: DewDiligence #2318

"Right now, we're in a huge spike of RSV," said Dr. Frank Esper, an infectious diseases expert at the Cleveland Clinic. RSV often affects babies but can also be problematic in adults with underlying lung problems, such as asthma and chronic obstructive pulmonary disease.

Esper said that cases of RSV are usually seen in December and January, but for the past two years, the typical RSV season has come earlier, during summer and early autumn. Rhinoviruses and enteroviruses are also circulating earlier than usual. This is because measures to curb Covid spread didn't allow other viruses to spread as they historically have.

"Flu off to an early start as CDC warns about potentially severe season"
https://www.yahoo.com/news/flu-off-early-start-cdc-235915662.html
==================================

With some luck the trials will be filled with greater ease than during Covid restrictions.

Both the RSV and Covid programs are short treatments and expedited approval processes.
It has been hard to be patient, I must say.